OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TRDA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Entrada Therapeutics (TRDA) Earnings Date & Reports

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TRDA is expected to report earnings to fall 4.69% to -99 cents per share on November 11

Entrada Therapeutics TRDA Stock Earnings Reports

Q3'25

Est.

$-0.99

Q2'25

Missed

by $0.22

Q1'25

Beat

by $0.31

Q4'24

Beat

by $0.70

Q3'24

Beat

by $0.38

The last earnings report on August 06 showed earnings per share of -103 cents, missing the estimate of -81 cents. With 165.15K shares outstanding, the current market capitalization sits at 230.89M.

View a ticker or compare two or three

Compare

TRDA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TRDA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading for TRDA

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Design Center Place

Phone

+1 857 520-9158

Employees

159

Web

https://www.entradatx.com